HOUSTON--(BUSINESS WIRE)--Bio-Path Holdings, Inc. (OTCBB: BPTH), a publicly traded biotechnology company with drug development operations in Houston, Texas, announced today it has retained Alliance Advisors, LLC as the Company’s investor relations firm. Alliance Advisors will immediately initiate a proactive and targeted investor relations campaign. Alan Sheinwald, President of Alliance Advisors, and his team will be advising the Company in all facets of public financial communications.
